Proteomics Shared Resource (PSR) The goal of the Proteomics Shared Resource (PSR) is to enable University of Arizona Cancer Center (UACC) investigators to identify and characterize proteins and peptides and their modifications using modern proteomics methods. The PSR provides twenty distinct proteomics services that enable the systematic analysis of protein identification and characterization, including quantification and mapping modifications, via state-of-the-art modern mass spectrometry and peripheral instrumentation. PSR equipment includes an array of proteomics instrumentation including 2D and 3D quadrupole ion traps, hybrid mass analyzers (Waters QTOF Premier and the AB Sciex 4000 QTRAP), an AB Sciex triple quadruple mass analyzer and MALDI-TOF mass spectrometer, and a linear quadrupole ion trap Orbitrap Velos high-resolution and high-accuracy mass spectrometer system with CID/HCD/ETD. All mass analyzers are full LC-MS/MS systems, with the exception of the MALDI-TOF system. A comprehensive set of proteomics services are offered to UACC members at very affordable rates. Free-of-charge unlimited assistance and consultation with experimental design, planning, data mining, and data interpretation are also offered to UACC members. The PSR staff provides training for users when requested.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA023074-36
Application #
9149091
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
36
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Kobes, Joseph E; Georgiev, George I; Louis, Anthony V et al. (2018) A Comparison of Iron Oxide Particles and Silica Particles for Tracking Organ Recellularization. Mol Imaging 17:1536012118787322
Kelly, K R; Espitia, C M; Zhao, W et al. (2018) Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy. Leukemia 32:230-233
Downs, Charles A; Johnson, Nicholle M; Tsaprailis, George et al. (2018) RAGE-induced changes in the proteome of alveolar epithelial cells. J Proteomics 177:11-20
Sun, Virginia; Wendel, Christopher S; Demark-Wahnefried, Wendy et al. (2018) Diet and Behavior Modifications by Long-term Rectal Cancer Survivors to Manage Bowel Dysfunction-Associated Symptoms. Nutr Cancer :1-11
Mushtaq, Adeela; Kapoor, Vikas; Latif, Azka et al. (2018) Efficacy and toxicity profile of carfilzomib based regimens for treatment of multiple myeloma: A systematic review. Crit Rev Oncol Hematol 125:1-11
Rak, Michael A; Buehler, Jason; Zeltzer, Sebastian et al. (2018) Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency. J Virol 92:
Rojo de la Vega, Montserrat; Zhang, Donna D; Wondrak, Georg T (2018) Topical Bixin Confers NRF2-Dependent Protection Against Photodamage and Hair Graying in Mouse Skin. Front Pharmacol 9:287
Bea, Jennifer W; de Heer, Hendrik Dirk; Valdez, Luis et al. (2018) Physical Activity among Navajo Cancer Survivors: A Qualitative Study. Am Indian Alsk Native Ment Health Res 25:54-73
Siyahian, Aida; Malik, Saad Ullah; Mushtaq, Adeela et al. (2018) Prophylaxis for Hepatitis B Virus Reactivation after Allogeneic Stem Cell Transplantation in the Era of Drug Resistance and Newer Antivirals: A Systematic Review and Meta-Analysis. Biol Blood Marrow Transplant 24:1483-1489
Stanton, Annette L; Wiley, Joshua F; Krull, Jennifer L et al. (2018) Cancer-related coping processes as predictors of depressive symptoms, trajectories, and episodes. J Consult Clin Psychol 86:820-830

Showing the most recent 10 out of 1336 publications